FDA Inspection
Teva Parenteral Medicines, Inc.Teva Parenteral Medicines, Inc. – FDA Inspection, Jun 4, 2013
Record Details
This FDA Inspection record concerns Teva Parenteral Medicines, Inc., with an inspection on June 4, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 4, 2013
- Product Type
- Drugs
View Company Profile
ID · 3d2dc942-c974-44a5-93ac-a292b067dfb8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 834806
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Parenteral Medicines, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| August 20, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | NAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| January 18, 2019 | VAI | Los Angeles District Office | Generic Drug Evaluation |
| December 19, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Parenteral Medicines, Inc.
- FDA Inspection 1149378 - 2021-08-20
- FDA Inspection 1100853 - 2019-08-30
- FDA Inspection 1077528 - 2019-01-18
- FDA Inspection 997582 - 2016-12-19
- FDA Inspection 980903 - 2016-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.